- Research article
- Open Access
Expression of bioactive bone morphogenetic proteins in the subacromial bursa of patients with chronic degeneration of the rotator cuff
Arthritis Research & Therapy volume 8, Article number: R92 (2006)
Degeneration of the rotator cuff is often associated with inflammation of the subacromial bursa and focal mineralization of the supraspinatus tendon. Portions of the supraspinatus tendon distant from the insertion site could transform into fibrous cartilage, causing rotator-cuff tears owing to mechanical instability. Indirect evidence is presented to link this pathology to ectopic production and secretion of bioactive bone morphogenetic proteins (BMPs) from sites within the subacromial bursa. Surgically removed specimens of subacromial bursa tissue from patients with chronic tears of the rotator cuff were analyzed by immunohistochemistry and reverse transcription-PCR. Bioactive BMP was detected in bursa extracts by a bioassay based on induction of alkaline phosphatase in the osteogenic/myogenic cell line C2C12. Topical and differential expression of BMP-2/4 and BMP-7 mRNA and protein was found in bursa tissue. The bioassay of C2C12 cells revealed amounts of active BMP high enough to induce osteogenic cell types, and blocking BMP with specific antibodies or soluble BMP receptors Alk-3 and Alk-6 abolished the inductive properties of the extract. Sufficient information was gathered to explain how ectopic expression of BMP might induce tissue transformation into ectopic bone/cartilage and, therefore, promote structural degeneration of the rotator cuff. Early surgical removal of the subacromial bursa might present an option to interrupt disease progression.
Alterations to the rotator cuff owing to chronic degenerative and traumatic lesions are not only frequently diagnosed in the elderly, but are also seen as a result of occupational or sports activities. It is also widely accepted that cuff ruptures attributed to an accident mostly occur in patients suffering from asymptomatic degenerative lesions of the tendon.
Chronic degeneration of the rotator cuff frequently presents as an 'impingement syndrome', with painful restriction of joint mobility. X-rays can reveal dense clouds within the tendon, establishing the diagnosis of 'tendinosis calcarea' as an additional pathologic trait. Ultrasound or magnetic resonance imaging usually demonstrates an enlarged subacromial bursa adjacent to the rotator-cuff lesion. Surgical treatment focuses on anatomic and functional reconstruction. Nevertheless, the results are often poor. Even after debridement of the torn tendon, followed by suturing or osseous reattachment, the tissue does not better: does not re-adjust to the functional and mechanical demands. As a result, nearly two-thirds of surgically reconstructed rotator cuffs experience a re-rupture [1, 2]. This clinical dilemma emphasizes that the underlying pathomechanisms involving the rotator-cuff tendon and subacromial bursa are not yet understood.
One of the pathologic hallmarks is inflammation, with consequent hypertrophy of the subacromial bursa [3, 4]. Hypertrophy of the bursa is regarded as one of the causes of the chondroid transformation of the supraspinatus tendon because the expanded bursa tissue can act on the tendon and surrounding tissues. Expansion of the bursa, however, does not explain calcification of the tendon. Therefore, tendinosis calcarea is classified as a separate disease entity, although quite frequently co-existing with an impingement syndrome attributable to rotator-cuff tears [5–8].
Here, we present evidence that chronic degeneration of the rotator cuff is associated with inflammation-related induction of bone morphogenetic protein (BMP) activity in the joint. The deposition and activation of significant quantities of BMP could, in part, explain the observed rotator-cuff pathologies, together with inflammation-induced proliferation of connective tissue. BMP might induce differentiation of competent cell types, such as mesenchymal precursors, tendon cells, and other soft tissue cells, into osteochondral lineages, to form ectopic populations of (fibro-) cartilage and mineralized tissues. To support this hypothesis, experiments were carried out to define the level of BMP and its activity within the affected subacromial bursa.
Materials and methods
Subacromial bursa was harvested from a total of 29 patients (age range, 36–75 years; median age, 57 ± 9.8 years; normal distribution (Kolmogorov-Smirnov) during surgical interventions to address rotator-cuff tears, with patient consent and institutional approval (approval #0981-10/02 from the Ethics Committee of the Medical Faculty at the University of Jena, Jena, Germany). Two patients were acute trauma cases who received emergency shoulder surgery and served as donors of 'normal' bursa tissue. The tissue was collected in an oriented fashion and immediately frozen using dry ice. Aliquots from segments close to the acromion, the medial portion, the basal portion, and close to the tendon (containing tendineus tissue) were excised using a 2.5-mm tissue punch, placed into an RNA extraction solution (TRIzol™ reagent; Life Technologies, Invitrogen, Carlsbad, CA, USA), and stored at -80°C. The deep-frozen tissue was also stored at -80°C before use.
Bone morphogenetic protein extraction
Deep-frozen tissue was placed into 4 M guanidinium/HCl (approximately 1 ml/100 mg tissue), which was supplemented with protease inhibitors (0.1 mM phenylmethanesulfonylfluoride, 0.1 mM N-ethylmaleinimide, and 5 mM ethylendiaminetetraacetic acid). Extraction was performed overnight at 4°C. The enrichment of BMP followed established procedures. The extract was centrifuged at 10,000 rpm in a microvial centrifuge and then exhaustively dialyzed against column buffer (0.05 M Na-acetate and 30% isopropanol; pH 5.0). The clear solution was placed on top of a small bed of MonoS beads (GE Healthcare, Munich, Germany) in a 10 ml syringe and allowed to flow by gravity. The beads were washed with column buffer, and the bound protein was stepwise eluted with 0.1 M, 0.5 M, and 1 M NaCl in column buffer. Typically, most of the BMP activity was detected in the 0.5 M NaCl fraction. The eluates were concentrated by lyophilization and dialyzed against PBS before being applied to the cell culture.
The osteogenic mouse precursor cell line C2C12 (purchase number CRL-1772) was purchased from American Type Culture Collection (ATCC) (LGC Promochem GmbH, Germany) and routinely cultured at low density in Dulbecco's' modified Eagle's medium supplemented with 10% fetal calf serum, with serial passages by trypsination. The serum was pretested to ensure that it contained as little as possible osteogenic activity towards C2C12 . For testing the extract, 1,000 cells/well were placed into 96-well microplates and allowed to adhere overnight. Medium was then exchanged with medium containing defined amounts of extract respectively recombinant human BMP-2  and BMP-7 (Stryker Biotech, Hopkinton, MA, USA) standards, plus 10 μg/ml vitamin C and 20 nM vitamin D (cholecalciferol, Sigma-Aldrich, Munich, Germany). After 5 days of cultivation, the medium was removed and cells were washed once with PBS before determination of alkaline phosphatase (AP) activity, as a marker for osteogenic activation. To detect localized BMP activity in bursa tissue, frozen sections (10 μm) were dried onto sterile glass slides and 10,000 C2C12 cells were seeded onto each slide. Following 5 days of incubation, the cells were fixed with 4% paraformaldehyde in PBS and submitted to AP detection, as described below.
AP activity in 96-well C2C12 cultures was detected and quantified using an AP chemiluminescence detection kit (Roche Diagnostics GmbH, Mannheim, Germany). As a calibration, purified AP (activity 35,820 units/ml; EMD Biosciences, VWR DEUTSCHLAND GMBH, Darmstadt, Germany) was serially diluted and allowed to react with the kit in parallel wells without cells. Detection of bioluminescence was performed in a FluorS MultiImager (Bio-Rad Munich, Germany). Enzyme activity was evaluated against a calibration curve in the activity range from 1791 down to 17.91 μU (regression coefficient, >0.9) with purified bone AP. Significance (P) was calculated with a paired t test, comparing quadruplicates from the control group with each treatment group. For qualitative detection of AP activity in histological sections, frozen sections or paraffin-embedded sections (after deparaffination) were incubated with an NBT/BCIP detection kit (Roche Diagnostics GmbH, Mannheim, Germany), forming a dark blue precipitate. Levamisole (0.5 mM) was used, as directed by the manufacturer, to differentiate bone AP from other isoenzymes.
RNA and reverse transcription-PCR
Reverse transcription-PCR (RT-PCR) was applied to detect mRNA of BMP, matrix proteins, and inflammatory cytokines (primers and conditions; Table 1). The primers were optimized for performance. Sequence specificity was tested by BLAST searches . Total RNA was isolated from the TRIzol™ extract according to the manufacturer's protocol and stored at -80°C before use. Aliquots were submitted to reverse transcription, amplified by PCR, analyzed in 0.8% agarose gels, and normalized to glucosealdehyde phosphate dehydrogenase (GAPDH) and actin mRNA. The bands were visualized in a FluorS MultiImager.
The real-time quantitative RT-PCR reactions were carried out, using an iCycler 'iQ Real-Time PCR' instrument (Bio-Rad Munich, Germany) and an 'IQ SYBR Green Supermix' (Bio-Rad Munich, Germany), with primers that specifically amplified the transcripts of the genes of interest. The primers used for qRT-PCR were the same as those used for RT-PCR, with the exception of GAPDH, type II collagen, and tumor growth factor (TGF)-β mRNA-specific primer pairs. These were as follows (upstream and downstream primers, and expected product size (base pairs (bp))):for GAPDH, 5'-CATCACTGCCACCCAGAAGA-3', 5'-CCTGCTTCACCACCTTCTTG-3', and 254 bp (NCBI: NM_000660); for type II collagen, 5'-CAACACTGCCAACGTCCAGAT-3', 5'-CTGCTTCGTCCAGATAGGCAAT-3' , and 107 bp; for TGF-β, 5'-CGGCAGCTGTACATTGACTT-3', 5'-AGCGCACGATCATGTTGGAC-3', and 270 bp [NCBI: NM_002046]
An example of the standard curves obtained is given in Figure 1, including a calibration curve for an unknown sample. Each sample was measured in duplicates, with a 2.3% average error of measurement determined across all samples. Relative gene-expression levels were calculated as 2(ΔCt), with GAPDH used for normalization [12–15].
Frozen sections (5 μm) were obtained from the deep-frozen bursae and stained by indirect immunofluorescence procedures. Mouse monoclonal antibodies were chosen for BMP-2/4 (final concentration, 2.5 μg/ml; MAB 355, R&D Systems,) and for BMP-7 (final concentration, 40 μg/ml; MAB 3541, R&D Systems, Wiesbaden.Nordenstadt, Germany). Parallel sections were stained to obtain information on approximate co-localization and BMP activity on application to C2C12 cells (see above).
Statistical analysis and graphs
Statistical calculations were performed using SigmaStat 3.0 (SPSS GmbH, Munich, Germany). The graphs were made with SigmaPlot 8.0 (SPSS).
Immunohistology and histochemistry
The overall morphology of the inflamed bursa has been described by others . The top portion, close to the acromion, looks similar to synovial tissue with lining cells. The center comprises reticular connective tissue and fat tissue, with vessel structures that seem not only to be arterioles and venules, but also elements similar to interdigitations of the synovial lining. The bottom portion, close to the tendon, displays the morphology of dense connective tissue, with transition to a classical tendon-like structure. There were bursa tissues from patients with various degrees of degeneration if amounts of fat tissue and disorganized connective tissue were selected as pathologic signs. But with the absence from the literature of an established histological grading system for subacromial bursa pathology, we refrained from discriminating grades or stages. Collagen type I is present between the lobular elements in the supporting reticular tissue of the bursa and the supraspinatus tendon fibers reaching into the basal portion of the organ, in addition to the dense connective tissue between the bursa and the tendon (Figure 2b). Although we detected collagen type II mRNA in most specimens (see below), collagen type II protein was detected only in some cases and only with spotty distribution, preferentially towards or within the tendon. Elements staining positive included reticular fibers, dense connective tissue fibers proximal to the tendon, and the tendon (Figure 2c). Safranin O staining, an indicator of large deposits of proteoglycan, was negative (not shown). This is in agreement with the absence of mRNA for aggrecan in this tissue (see below).
Within these structures, there were significant deposits of BMP-2 and BMP-7, as visualized by indirect immunofluorescence staining. The staining was concentrated in islets of high cellularity (Figure 3a,b), vessel walls (Figure 3c,d), and segmentally arranged lining cells (see below) rather than along connective tissue fiber structures. The dense connective tissue and tendon were mostly negative.
Bone AP, which could be inhibited by 5 mM levamisole to differentiate it from leukocyte AP, was detected preferentially within the bursa, not the tendon, and always close to vessel or duct structures and the acinar elements in the acromial portion (Figure 4).
Expression of mRNA for bone morphogenetic protein, matrix proteins, and cytokines
Figures 5 and 6 show the results of expression profiles obtained from areas of the bursa that are proximal to the acromion, central, proximal to the tendon, and underlying the supraspinatus tendon segment. As expected, mRNA for collagen types I and III are present in all samples. Collagen type II, the major collagen type in chondrocytes, is significantly expressed within the bursa and underlying tendineus tissue of samples from almost all patients (Figures 5 and 6), possibly a sign of the ongoing transformation of tendon to cartilage. The ratio of collagen type II to GAPDH mRNA in diseased tissue is less than or equal to 0.2, whereas in healthy tissue it is 0.02. By contrast, freshly isolated adult articular chondrocytes can have a collagen type II/GAPDH mRNA ratio of up to 100 (unpublished data). Interestingly, collagen type X expression (Figures 5 and 6) within the bursa is higher than in the tendon (ratios of collagen type X mRNA to GAPDH mRNA of less than or equal to 0.3 and 0.04, respectively); such ratios in adult cartilage (Mollenhauer JA, unpublished data) are not different from those found in the diseased bursa tissue. Collagen type X is usually expressed in hypertrophic cartilage and is associated with mineralization processes; it is contained in mineralizing vesicles. In all of the samples tested there was no mRNA for the large cartilage proteoglycan aggrecan. However, in RNA prepared from articular cartilage, aggrecan mRNA was strongly displayed using the same RT-PCR conditions (Figure 5).
mRNA for growth factors of the TGF-β superfamily was found in all samples (some stratification was typical), with the following order of magnitude: TGF-β (in a ratio to GAPDH of 0.3) > BMP-7 (in a ratio to GAPDH of 0.03) > BMP-2 (in a ratio to GAPDH of 0.001). BMP-2 did not show preferential sublocation in its expression; however, BMP-7 mRNA in the acromial portion of the diseased bursa was approximately two orders of magnitude higher than in the healthy samples (in a ratio to GAPDH of 0.09 compared with 0.0009, respectively), representing the largest difference in growth factor expression between diseased and healthy tissues.
As examples of alternative tissue growth factors, fibroblast growth factor (FGF)-2 and vascular endothelial growth factor (VEGF) mRNA was also present and helps to explain the proliferation of the bursa into granulation tissue, with loose connective tissue and blood vessels amply present. However, FGF-2 mRNA levels were low throughout the tissue – the ratio of FGF-2 mRNA to GAPDH mRNA was about 10 times lower than the ratio of BMP mRNA to GAPDH mRNA- and was not preferentially localized within the bursa. Of the family of inflammatory cytokines, we tested for interleukin (IL)-1 and tumor necrosis factor (TNFα. As in the present example, typically IL-1β mRNA was not prominent, whereas TNF-α mRNA was always expressed, in particular within the top portion of the bursa. Figure 5b shows a representative cross-sectional mRNA analysis from 14 patients.
Biogenic bone morphogenetic protein activity
We decided on a bioassay for differentiation rather than directly determining quantities of specific BMPs. Although measuring BMP concentrations is an exact method, no information is given on the bioactivity, because molecules might exist in an inactive pro-form, partially degraded or denatured, or in mixtures that cancel out effects on differentiation. The C2C12 cell line is an established detector of BMP type I receptor-related BMP activity owing to its induction of AP . On the basis of this receptor constellation, BMP-2 and BMP-4 should be initiators of osteogenic differentiation. However, we also found, although to a lesser degree, that BMP-7 could induce AP within these cells. In the extract, we found that the BMP equivalent induced 380 ± 135 μU AP/100 mg of bursa tissue, with the medium control displaying 175 ± 51 μU AP/100 mg of bursa tissue (P = 0.0163). By contrast, under the same conditions, 25 ng/ml recombinant BMP-2 induced 460 ± 154 μU AP/100 mg of bursa tissue (P = 0.0021) and 50 ng/ml of recombinant BMP-7 induced 430 ± 111 μU AP/100 mg of bursa tissue (P = 0.0058). BMP activity could be completely abolished by incubation with neutralizing antibodies against BMP-2 and BMP-7, in addition to incubation with the soluble BMP receptors Alk-3 and Alk-6 (not shown).
Because the extraction process does not enable determination of the original site of expression within the bursa tissue, we tested frozen sections of bursa tissue for their ability to induce AP locally in C2C12 cells seeded onto a frozen section. Surprisingly, the cells not only started to express AP, but also expression was confined to the location where we detected BMP-2 and BMP-7 in parallel sections (Figure 7). No activation of AP expression took place distant from those sites. Although the microwell assay worked well with the BMP extract (BMP in solution), the result from the 'contact' experiment indicates that BMP might also exert its effect strictly locally, thus avoiding lateral expansion of the differentiation signal.
Degenerative alterations to the rotator cuff are generally regarded as the consequence of mechanical abutment, undefined 'rheumatoid' inflammation, or previous accident. Although these causes could describe possible etiologies, they do not completely explain the cellular and molecular alterations seen in and around the rotator cuff, such as chondrogenic transformation and ectopic mineralization of the tendon tissue. With the present set of data, an additional perspective towards a causative explanation is given: chronic activation of morphogenetic factors (BMP-2, BMP-7, TGF-β, VEGF, and FGF) that might actively contribute to the rise of mechanically incompetent and (because of the mineral deposits) chronically irritating tissue components. The differential expression of BMP-2 and BMP-7, with BMP-7 expressed in a decreasing gradient from acromion to tendon, suggests a distinct contribution of BMP-7 to the disease process. Additional expression of inflammatory cytokines (IL-1β and TNF-α) might serve in propagating local inflammation and tissue destruction.
In bursa samples from patients with ruptures of the rotator cuff, expression of collagen types I and III was enhanced compared with normal controls . In addition, enhanced expression of IL-1β, both secreted and cell-bound IL-1 receptor antagonists, and VEGF have been demonstrated [4, 17, 18]. Participation of the bursa in the disease progression of the rotator cuff has also been shown in animal experiments with rabbits  and chickens . Specifically, chemical induction of a bursitis-induced chondrogenic metaplasia of the supraspinatus insertion site . These reports are not only in line with our findings, but also strongly suggest significant influence of molecular events within the subacromial bursa on the fate of the underlying supraspinatus tissue.
Unfortunately, there is no recent literature on the histology of the normal bursa. Organ material from tumor-related and joint-replacement surgery was available but always showed signs of degeneration, depending on the primary disease, and was thus unrepresentative of a normal situation. Nonetheless, the presence of bioactive BMP in itself supports the hypothesis of its role in induced chondrogenesis, irrespective of whether and, if so, how much it is expressed in normal tissue.
The amounts of BMP we detected are quite significant. Although direct estimates are hard to compare, the mid-ng quantities/mg of bursa tissue represent an overwhelmingly strong potential for morphogenetic signaling. In particular, the in-situ transformation that was achieved by placing the detector cell line C2C12 onto tissue slices reveals the effectiveness of the deposited BMP within the bursa. BMP detected within the cell and extracellular matrix of blood vessels might have been transported there through the bloodstream. However, the microanatomic distribution of immunohistological signals and the results from the PCR analysis strongly suggest local production rather than introduction from outside the bursa. Because we could block the differentiation signal by incubating the extracts with anti-BMP antibodies or soluble BMP receptors, a dominant role of BMPs in activating tissue transdifferentiation can be assumed, although a contribution of other growth factors cannot be excluded.
Because of the normal function of the bursa, the BMP might reach the tendon tissue through anatomic secretion pathways from the glandular elements within the bursa. Unfortunately, too little is reported in the literature about the secretary activity of this normally rather inconspicuous layer of tissue underneath the acromion. It is obvious, however, that there was significant cartilage differentiation, with RNA levels for cartilage collagen types II and X at quite significant levels in parts of the patients' tissue. Collagen to GAPDH ratios of >0.1, as detected here, are usually found in normal articular, mineralizing, and osteoarthritic tissue [22, 23]. In addition, studies performed in the rat support our observation of long-term preservation of cartilage-related gene expression in the supraspinatus .
There is some information on the production and role of BMP in adult soft tissue. BMP is produced by gingival and periodontal fibroblasts , megakaryocytes and platelets , cells supporting egg maturation [27, 28], the kidney , and also connective tissue tumor cells. More importantly, arthritic synovial membranes have been shown to express BMP-2 and BMP-6 and can influence cell turnover . Early studies showed that BMP induces tissue transdifferentiation of tenocytes into chondrocytes in vitro  and, more recently, studies showed BMP-induced transdifferentiation of kidney fibroblasts into epithelial cells . Our finding in itself is not unexpected, retrospectively, but so far, to our knowledge, no attempts have been made to directly link the 'shoulder syndrome' to ectopic overexpression of BMP. Our approach using AP differentiation within the C2C12 cell line gave us a tool to explore primary features of the BMP deposited within the bursa. However, to describe the entire pathologic pathway from soft tissue to mineral deposits and fiber cartilage, more experiments are needed using chondrocytes and primary mesenchymal precursor cells in vitro or with exogenous deposits of defined BMP in animals.
In the absence of pharmacologic strategies to counteract untoward BMP activity, only surgical intervention is an option for curative approaches to preventing eventually dramatic outcomes, such as in cases of ossification of the rotator cuff . Complete excision of the subacromial bursa either before acute rupture or during restorative surgery of torn ligaments or the tendon might represent the only option we currently have.
= alkaline phosphatase
= bone morphogenetic protein
= threshold cycle number for amplified cDNA
= fibroblast growth factor
= glyceroaldehydephosphate dehydrogenase
= phosphate-buffered saline
= tumor growth factor
tumor necrosis factor
= vascular endothelial growth factor.
Cordasco FA, Backer M, Craig EV, Klein D, Warren RF: The partial-thickness rotator cuff tear: is acromioplasty without repair sufficient?. Am J Sports Med. 2002, 30: 257-260.
Knudsen HB, Gelineck J, Sojbjerg JO, Olsen BS, Johannsen HV, Sneppen O: Functional and magnetic resonance imaging evaluation after single-tendon rotator cuff reconstruction. J Shoulder Elbow Surg. 1999, 8: 242-246. 10.1016/S1058-2746(99)90136-2.
Suenaga N, Minami A, Fukuda K, Kaneda K: The correlation between bursoscopic and histologic findings of the acromion undersurface in patients with subacromial impingement syndrome. Arthroscopy. 2002, 18: 16-20.
Yanagisawa K, Hamada K, Gotoh M, Tokunaga T, Oshika Y, Tomisawa M, Lee YH, Handa A, Kijima H, Yamazaki H, et al: Vascular endothelial growth factor (VEGF) expression in the subacromial bursa is increased in patients with impingement syndrome. J Orthop Res. 2001, 19: 448-455. 10.1016/S0736-0266(00)90021-4.
Simon HW: Soft tissue disorders of the shoulder. Frozen shoulder, calcific tendinitis, and bicipital tendinitis. Orthop Clin North Am. 1975, 6: 521-539.
Uhthoff HK, Sano H: The rotator cuff, part I. Pathology of failure of the rotator cuff tendon. Orthop Clin North Am. 1997, 28: 31-41. 10.1016/S0030-5898(05)70262-5.
Halverson PB: Crystal deposition disease of the shoulder (including calcific tendonitis and Milwaukee shoulder syndrome). Curr Rheumatol Rep. 2003, 5: 244-247.
Molloy ES, McCarthy GM: Hydroxyapatite deposition disease of the joint. Curr Rheumatol Rep. 2003, 5: 215-221.
Katagiri T, Yamaguchi A, Komaki M, Abe E, Takahashi N, Ikeda T, Rosen V, Wozney JM, Fujisawa SA, Suda T: Bone morphogenetic protein-2 converts the différentiation pathway of C2C12 myoblasts. J Cell Biol. 1994, 127: 1755-1766. 10.1083/jcb.127.6.1755.
Gründer T, Gaissmaier C, Fritz J, Stoop R, Hortschansky P, Mollenhauer J, Aicher WK: Bone morphogenetic protein (BMP)-2 enhances the expression of type II collagen and aggrecan in chondrocytes embedded in alginate beads. Osteoarthritis Cartilage. 2004, 12: 559-567. 10.1016/j.joca.2004.04.001.
Altschul SF, Madden TL, Schäffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ: Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res. 1997, 25: 3389-3402. 10.1093/nar/25.17.3389.
Fan Z, Bau B, Yang H, Soeder S, Aigner T: Freshly isolated osteoarthritic chondrocytes are catabolically more active than normal chondrocytes, but less responsive to catabolic stimulation with interleukin-1beta. Arthritis Rheum. 2005, 52: 136-143. 10.1002/art.20725.
Melby PC, Darnell BJ, Tryon VV: Quantitative measurement of human cytokine gene expression by polymerase chain reaction. J Immunol Methods. 1993, 159: 235-244. 10.1016/0022-1759(93)90162-Z.
Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2-(-Delta Delta C(T)) method. Methods. 2001, 25: 402-408. 10.1006/meth.2001.1262.
Ferreira ID, Rosario VE do, Cravo PV: Real-time quantitative with SYBR Green I detection for estimating copy numbers of nine drug resistance candidate genes in Plasmodium falciparum. Malaria Journal. 2006, 5: 1-10.1186/1475-2875-5-1.
Tomonaga A, Hamada K, Gotoh M, Yamakawa H, Kobayashi K, Fukuda H: Expression of procollagen alpha 1 type III mRNA in rotator cuff tears. Tokai J Exp Clin Med. 2000, 25: 125-134.
Gotoh M, Hamada K, Yamakawa H, Yanagisawa K, Nakamura M, Yamazaki H, Ueyama Y, Tamaoki N, Inoue A, Fukuda H: Interleukin-1 induced subacromial synovitis and shoulder pain in rotator cuff diseases. Rheumatology. 2001, 40: 995-1001. 10.1093/rheumatology/40.9.995.
Sakai H, Fujita K, Sakai Y, Mizuno K: Immunolocalization of cytokines and growth factors in subacromial bursa of rotator cuff patients. Kobe J Med Sci. 2001, 47: 25-34.
Uhthoff HK, Sano H, Trudel G, Ishii H: Early reactions after replantation of the tendon of supraspinatus into bone. A study in rabbits. J Bone Joint Surg Br. 2000, 82: 1072-1076. 10.1302/0301-620X.82B7.9986.
Kobayashi K, Hamada K, Gotoh M, Handa A, Yamakawa H, Fukuda H: Healing of full-thickness tears of avian supracoracoid tendons: in situ hybridization of alpha1(I) and alpha1(III) procollagen mRNA. J Orthop Res. 2001, 19: 862-868. 10.1016/S0736-0266(01)00015-8.
Tillander B, Franzén LE, Nilsson E, Norlin R: Carrageenan-induced subacromial bursitis caused changes in the rat's rotator cuff. J Orthop Res. 2001, 19: 441-447. 10.1016/S0736-0266(00)90022-6.
Fan Z, Bau B, Yang H, Soeder S, Aigner T: Freshly isolated osteoarthritic chondrocytes are catabolically more active than normal chondrocytes, but less responsive to catabolic stimulation with Interleukin-1. Arthritis Rheum. 2005, 52: 136-143. 10.1002/art.20725.
Gebauer M, Saas J, Haag J, Dietz U, Takigawa M, Bartnik E, Aigner T: Repression of anti-proliferative factor Tob1 in osteoarthritic cartilage. Arthritis Res Ther. 2005, 7: R274-R284. 10.1186/ar1479.
Yokota A, Gimbel JA, Williams GR, Soslowsky LJ: Supraspinatus tendon composition remains altered long after tendon detachment. J Shoulder Elbow Surg. 2005, 14 (1 Suppl S): 72S-78S. 10.1016/j.jse.2004.09.021.
Ivanovski S, Li H, Haase HR, Bartold PM: Expression of bone associated macromolecules by gingival and periodontal ligament fibroblasts. J Periodontal Res. 2001, 36: 131-141. 10.1034/j.1600-0765.2001.360301.x.
Sipe JB, Zhang J, Waits C, Skikne B, Garimella R, Anderson HC: Localization of bone morphogenetic proteins (BMPs)-2, -4, and -6 within megakaryocytes and platelets. Bone. 2004, 35: 1316-1322. 10.1016/j.bone.2004.08.020.
Pierre A, Pisselet C, Dupont J, Mandon-Pepin B, Monniaux D, Monget P, Fabre S: Molecular basis of bone morphogenetic protein-4 inhibitory action on progesterone secretion by ovine granulosa cells. J Mol Endocrinol. 2004, 33: 805-817. 10.1677/jme.1.01545.
Glister C, Kemp CF, Knight PG: Bone morphogenetic protein (BMP) ligands and receptors in bovine ovarian follicle cells: actions of BMP-4, -6 and -7 on granulosa cells and differential modulation of Smad-1 phosphorylation by follistatin. Reproduction. 2004, 127: 239-254. 10.1530/rep.1.00090.
Ozkaynak E, Schnegelsberg PN, Oppermann H: Murine osteogenic protein (OP-1): high levels of mRNA in kidney. Biochem Biophys Res Commun. 1991, 179: 116-123. 10.1016/0006-291X(91)91342-A.
Lories RJ, Derese I, Ceuppens JL, Luyten FP: Bone morphogenetic proteins 2 and 6, expressed in arthritic synovium, are regulated by proinflammatory cytokines and differentially modulate fibroblast-like synoviocyte apoptosis. Arthritis Rheum. 2003, 48: 2807-2818. 10.1002/art.11389.
Sato K, Miura T, Iwata H: Cartilaginous transdifferentiation of rat tenosynovial cells under the influence of bone morphogenetic protein in tissue culture. Clin Orthop Relat Res. 1988, 236: 233-239.
Zeisberg M, Shah AA, Kalluri R: Bone morphogenic protein-7 induces mesenchymal to epithelial transition in adult renal fibroblasts and facilitates regeneration of injured kidney. J Biol Chem. 2005, 280: 8094-8100. 10.1074/jbc.M413102200.
Matsumoto I, Ito Y, Tomo H, Nakao Y, Takaoka K: Case reports: ossified mass of the rotator cuff tendon in the subacromial bursa. Clin Orthop Relat Res. 2005, 437: 247-250. 10.1097/01.blo.0000170720.91461.58.
The excellent technical assistance of Christine Mollenhauer and Cordula Mueller is gratefully acknowledged. This work was supported, in part, by a grant from the Interdisciplinary Center for Medical Research at the University of Jena (# TP 2.7), a grant from the Deutsche Forschungsgemeinschaft (AU 56/6-1), and both a research fellowship for MA and a grant from the German Ministry of Science and Technology (0313177).
The authors declare that they have no competing interests.
RF, JN, AV, and IS contributed equally to the preparation of the manuscript.
Authors’ original submitted files for images
Below are the links to the authors’ original submitted files for images.